Rosemary Harrup

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL

Constantine S. Tam, Judith Trotman, Stephen Opat et al. · Blood · 2019 · 355 citations · Full text

Detection of Hodgkin lymphoma within ovarian tissue

Sophie Bittinger, Simon Nazaretian, Debra A. Gook et al. · Fertility and Sterility · 2010 · 71 citations

Lymphoid Neoplasia, Hodgkin Lymphoma, Cancer Detection +7

Roxadustat for the treatment of anemia in patients with <scp>lower‐risk</scp> myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study

David H. Henry, John A. Glaspy, Rosemary Harrup et al. · American Journal of Hematology · 2021 · 53 citations · Full text

Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

Meghan C. Thompson, Rosemary Harrup, Catherine C. Coombs et al. · Blood Advances · 2022 · 51 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Venetoclax Retreatment +10